Czech Republic Pharmaceuticals & Healthcare Report Q2 2013: New Research Report Available at Fast Market Research
The Czech pharmaceutical market is the most developed in terms of spending and ease of operation in the Central and Eastern European region, but it continues to present challenges for drugmakers. Price erosion by regulatory agencies and blind bidding auctions drive prices down year-onyear. The open movement of goods and services in the European Union has given rise to an arbitrage opportunity for medicines, which certain businesses have exploited. While within the letter of the law, the impact of parallel...
View full press release